Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  GlaxoSmithKline plc    GS7   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo GlaxoSmithKline plc
Develops, manufactures and distributes vaccines and other pharmaceutical products

GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands.

It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare.

The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases.

The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis.

The Consumer Healthcare business markets a range of consumer health products based on scientific innovation.

The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.
Managers
NameAgeSinceTitle
Andrew Witty522008Chief Executive Officer & Executive Director
Philip Hampton532015Non-Executive Chairman
Simon Dingemans532011Chief Financial Officer & Executive Director
Birgitte Volck MD, PhD552016Head-Research & Development
Moncef Slaoui, PhD562006Executive Director & Chairman-Global Vaccines
Roy Malcolm Anderson692007Independent Non-Executive Director
Patrick J. T. Vallance, MD-2006Executive Director
Judy Carol Lewent682011Independent Non-Executive Director
Emma Walmsley-2010CEO-Designate & Executive Director
Lynn Laverty Elsenhans, MBA602012Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 5,401,616,062 4,852,618,028 89.8% 491,505,950 9.1% 89.8%
Shareholders
NameEquities%
BlackRock Investment Management (UK) Ltd. 207,257,650 4.22%
Legal & General Investment Management Ltd. 147,931,457 3.01%
The Vanguard Group, Inc. 118,400,253 2.41%
Capital Research & Management Co. (Global Investors) 93,088,701 1.90%
Norges Bank Investment Management 92,073,000 1.88%
Woodford Investment Management LLP 66,402,112 1.35%
State Street Global Advisors Ltd. 64,248,136 1.31%
Schroder Investment Management Ltd. 57,188,782 1.16%
Threadneedle Asset Management Ltd. 56,813,660 1.16%
Capital Research & Management Co. (World Investors) 56,248,284 1.15%
Holdings
NameEquities%Valuation
Aspen Pharmacare Holdings Limited (APNJ) 28,234,3796.19%585,499,423 USD
Innoviva Inc (INVA) 32,005,26029.4%342,456,282 USD
Theravance Biopharma Inc (TBPH) 9,644,80718.6%307,476,447 USD
JCR Pharmaceuticals Co Ltd (4552) 7,986,00024.6%195,208,027 USD
Crispr Therapeutics AG (CRSP) 3,220,6278.09%65,249,903 USD
Dong-A Socio Holdings Co Ltd (000640) 409,6936.77%53,085,737 USD
GlaxoSmithKline S.A.E. 76,161,37891.2%38,686,934 USD
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSM) 444,065,54137.1%22,203,277 USD
Oncomed Pharmaceuticals Inc (OMED) 2,607,5467.03%20,104,180 USD
Allergy Therapeutics plc (AGY) 10,118,0001.70%2,609,837 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PLC-1.67%93 604
JOHNSON & JOHNSON-1.13%309 896
ROCHE HOLDING LTD.0.39%200 025
PFIZER INC.-3.14%190 910
NOVARTIS AG-4.32%183 809
MERCK & CO., INC.4.99%170 419
SANOFI-1.66%103 847
GLAXOSMITHKLINE PLC-0.99%93 604
BAYER AG3.40%89 744
ELI LILLY AND CO3.77%84 253
BRISTOL-MYERS SQUIBB C..-14.44%83 561
ALLERGAN PLC2.29%80 575
NOVO NORDISK A/S-2.32%70 912
ABBOTT LABORATORIES5.02%69 635
ASTRAZENECA PLC-2.68%66 624
SHIRE PLC-6.21%48 335
TAKEDA PHARMACEUTICAL ..-2.67%32 870
ASTELLAS PHARMA INC-6.03%29 124
MYLAN NV-5.56%19 280
EISAI CO., LTD-5.58%16 761
CHUGAI PHARMACEUTICAL ..-0.89%16 565
Sector Pharmaceuticals - NEC
GlaxoSmithKline plc : Connections
Pearson Education Ltd.
Business Council for Britain
Pharmaceutical Research & Manufacturers of America
American Academy of Arts & Sciences
The Council for Industry & Higher Education
European Federation of Pharmaceutical Industries & Assns
The 100 Group
The University of Nottingham
National Theatre of Scotland
Sunoco Chemicals, Inc.
TFS Trial Form Support AB
United Way of Greater Philadelphia & Southern New Jersey
Office for Strategic Co-ordination of Health Research
French Academy of Sciences
GlaxoSmithKline, Inc.
Genome Research Ltd.
Biotechnology Innovation Organization
Glaxosmithkline Australia Pty Ltd.
United Kingdom Department for Business, Innovation & Skills
Rockefeller Family Trust, Inc.
Rice University
Massachusetts Institute of Technology
The Texas Medical Center
Sunoco Partners LLC
International AIDS Vaccine Initiative, Inc.
PhRMA Foundation
United Way of Greater Houston
Longwood Fund Management LLC
World Golf Foundation, Inc.
The Natural History Museum
Central Houston, Inc.
Institute of Medicine
The First Tee of Greater Houston
Company contact information
980 Great West road
TW8 9GS Brentford, Greater London
United Kingdom

Phone : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
Internet : http://www.gsk.com
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- ISIN Code :  GB0009252882
- Bloomberg Code :  GSK:LN
- Reuters Code :  GSK.L
- Datastream Code :  GSK
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem